Drug pricing

High drug costs, under-the-radar insurer policies can put patients in a bind as hefty copays mount.

The Biden administration is facing mounting pressure from states to let them import medicine from Canada to help lower prescription drug costs.

The settlement is the biggest known drug pricing payout by Centene, which also serves Oregon Health Plan members.

Provisions in Democrats' Medicare prescription drug pricing crack open the door to reforms that could have dramatic effects, experts say.

Oregon legislators, health policy analysts and industry experts discussed the barriers to affordable drugs at an Oregon Health Forum breakfast meeting in Portland on Tuesday.

Summary: On May 24, 2017, the Type 1 Diabetes Defense Foundation filed two new lawsuits in federal court with class-action law firm Keller Rohrback, L.L.P., seeking disclosure of manufacturers’ net realized prices on blood glucose test strips and emergency glucagon kits, both used in diabetes treatment. Following on T1DF’s insulin pricing lawsuit filed March 17, 2017 (Boss, et al. v. CVS, et al.), T1DF now joins with individual plaintiffs in test strip claim Prescott, et al. v. CVS, et al. and glucagon claim Bewley, et al. v. CVS, et al., expanding its consumer rights campaign against the unconscionable pricing of essential pharmaceuticals. These lawsuits are consistent with T1DF’s opposition to “rebates” and other hidden pricing practices that raise list prices for diabetes drugs and supplies while disincentivizing innovation, promoting clinical inertia, undermining therapeutic adherence and encouraging discrimination against people with diabetes.